Investing
Of the 224 companies analyzed, 98 received a clinical robustness score of zero.
Also: Oma Fertility emerges from stealth with $37.5 million in equity and debt financing, and payer data platform Abacus Insights scores $28 million.
The startup's smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.
It will use the funds to deepen its presence across Asia.
The company plans to bring its technology to 10,000 more doctors in the country.
The round comes nearly a year after the company announced a $66 million Series C.
Also: Digital pathology startup Proscia raises $37 million in Series C funding.
The startup said the round brings its total raise to more than $50 million.
During a panel discussion at Going Digital: Behavioral Health Tech 2022, investors discuss what's next for the space as funding slows down, and explore the value of direct-to-consumer tools.
Also: Healthcare professional networking and data platform H1 adds another $23 million to its Series C round, and chronic condition management company DarioHealth secures a loan facility of up to $50 million.